ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,308.13
      0.09%
      US Tech 100
      18,174.40
      0.58%
      Dow Jones
      39,806.77
      -0.49%
      Brent Oil
      83.485
      -0.13%
      Bitcoin
      69,591.93
      5.01%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. MaxCyte Inc (MXCT)

      7. MaxCyte Inc (MXCT) News

      MXCT

      MaxCyte (MXCT)

      MaxCyte Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MXCT
      DateTimeSourceHeadlineSymbolCompany
      05/07/20245:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MXCTMaxCyte Inc
      05/07/20244:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MXCTMaxCyte Inc
      05/07/20244:05PMGlobeNewswire Inc.MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 GuidanceNASDAQ:MXCTMaxCyte Inc
      04/10/20248:05AMGlobeNewswire Inc.MaxCyte to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:MXCTMaxCyte Inc
      04/02/20248:05AMGlobeNewswire Inc.MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines (BCMs)NASDAQ:MXCTMaxCyte Inc
      03/12/20244:05PMGlobeNewswire Inc.MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 GuidanceNASDAQ:MXCTMaxCyte Inc
      03/05/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MXCTMaxCyte Inc
      03/04/20245:39PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
      03/04/20244:05PMGlobeNewswire Inc.MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary ResultsNASDAQ:MXCTMaxCyte Inc
      02/26/20244:22PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MXCTMaxCyte Inc
      02/14/20244:26PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MXCTMaxCyte Inc
      02/14/202412:25PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MXCTMaxCyte Inc
      02/09/20248:05AMGlobeNewswire Inc.MaxCyte to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 and Participate in Upcoming Investor ConferencesNASDAQ:MXCTMaxCyte Inc
      02/01/20244:25PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MXCTMaxCyte Inc
      01/30/20244:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
      01/30/20248:05AMGlobeNewswire Inc.MaxCyte and Wugen Sign Strategic Platform License to Expedite Scale-Up of Clinical and Commercial Manufacturing of Wugen’s Investigational Allogeneic, Off-the-Shelf Cell Therapies for CancersNASDAQ:MXCTMaxCyte Inc
      01/26/20244:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MXCTMaxCyte Inc
      01/26/202411:49AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MXCTMaxCyte Inc
      01/23/20248:05AMGlobeNewswire Inc.MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy ProgramsNASDAQ:MXCTMaxCyte Inc
      01/08/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MXCTMaxCyte Inc
      01/08/20244:05PMGlobeNewswire Inc.MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:MXCTMaxCyte Inc
      01/04/20244:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
      01/03/20248:05AMGlobeNewswire Inc.MaxCyte and Lion TCR form Partnership to Support Global Expansion of Lion TCR's TCR-T Cell PipelineNASDAQ:MXCTMaxCyte Inc
      01/02/20242:00AMGlobeNewswire Inc.MaxCyte Confirms Appointment of Maher Masoud as President, Chief Executive Officer and DirectorNASDAQ:MXCTMaxCyte Inc
      12/28/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
      12/11/20234:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MXCTMaxCyte Inc
      12/11/20234:05PMGlobeNewswire Inc.MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023NASDAQ:MXCTMaxCyte Inc
      12/06/20234:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
      12/01/20235:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
      11/29/20234:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
       Showing the most relevant articles for your search:NASDAQ:MXCT